Xellera Therapeutics provides end-to-end GMP manufacturing for cell and gene therapies—from development through commercial scale. Our in-house capabilities enable the production of CAR-T, VST, iPSC, MSC, NK, and dendritic cell therapies, ensuring reliable, high-quality outputs that meet global regulatory and safety standards. https://www.xelleratherapeutics.com/services/custom-manufacturing-services/